Nanalysis Scientific Corp.
NSCIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.08 | -0.04 | 0.07 | -0.00 |
| FCF Yield | -3.01% | -7.04% | 6.59% | 2.05% |
| EV / EBITDA | -114.24 | -57.96 | -15,672.16 | -8.62 |
| Quality | ||||
| ROIC | -3.85% | -5.83% | -3.56% | 0.96% |
| Gross Margin | 21.85% | 24.28% | 25.64% | 34.05% |
| Cash Conversion Ratio | 0.21 | 0.74 | -2.05 | -0.14 |
| Growth | ||||
| Revenue 3-Year CAGR | 17.29% | 18.73% | 23.34% | 22.38% |
| Free Cash Flow Growth | 66.98% | -195.93% | 191.09% | 195.35% |
| Safety | ||||
| Net Debt / EBITDA | -51.94 | -21.89 | -5,102.00 | -2.82 |
| Interest Coverage | -4.73 | -5.13 | -3.26 | 1.14 |
| Efficiency | ||||
| Inventory Turnover | 1.77 | 1.63 | 1.70 | 1.85 |
| Cash Conversion Cycle | 82.66 | 73.40 | 54.46 | 65.05 |